An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Hyperammonemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, liver disorder, metabolic disease, nervous system disorder, ornithine carbamoyltransferase deficiency, urea cycle disorder	Active, not recruiting	Phase 3	2026-09-30		NCT06255782

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
iECURE, Inc.	2

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's Hospital of Colorado, Anshutz Medical Campus	Aurora	United States	2
Emory University School of Medicine	Atlanta	United States	47
Great Ormond Street Hospital	London	United Kingdom	15
Hopsital Sant Joan de Deu	Barcelona	Spain	1
Hospital Universitario 12 de Octubre	Madrid	Spain	359
Icahn School of Medicine at Mount Sinai	New York	United States	342
Oregon Health and Science University	Portland	United States	382
The Children's Hospital at Westmead	Sydney	Australia	4
The Newcastle upon Tyne Hospitals NHS Foundation Trust- Great North Children's Hospital	Newcastle upon Tyne	United Kingdom	1
The Royal Children's Hospital	Melbourne	Australia	6
UCLA Mattel Children's Hospital	Los Angeles	United States	13